A Phase III Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor Therapy
Clinical trial NCT06799546 · COMPLETED
Trial details
- NCT number
- NCT06799546
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-13
- Primary completion
- 2025-11-05
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.